The US House Financial Services Committee approved the Bitcoin reserve bill, known as the American Modernization Act (H.R. 8957), with a 28-21 vote. The bill aims to establish a clear framework for securing digital assets held by the federal government and protect financial sovereignty through self-custody. Despite this legislative progress, the bill's future is uncertain as Democrats, who largely oppose it, are predicted to regain control of the House in the November midterms, potentially stalling the bill's final passage. The bill also faces criticism from some Democrats who view it as benefiting crypto billionaires and political figures.
The US Bitcoin reserve bill is the story's subject, here is Pluang's market snapshot as of Sep 17, 2026 19:21 WIB: 44 of 50 major cryptocurrencies rose today. Kusama (KSM) gained 7.35% to Rp71.007 with 93% buy orders, Polkadot (DOT) rose 6.13% to Rp18.308 with 62% buy orders, while Zilliqa (ZIL) fell 6.60% to Rp51 with 38% sell orders.
In Q3 2026, websites on Cloudflare's network blocked 13.47% of AI crawler requests, more than double the 5.98% blocked a year earlier. This rise in access denial affects how brands appear in AI-generated answers from platforms like ChatGPT, Gemini, a...
JPMorgan Asset Management (Canada) announced the final cash distributions for September 2026 for three of its ETFs traded on the Toronto Stock Exchange. Unitholders of record on October 19, 2026, will receive payments on October 23, 2026. The ETFs an...
Stillwater Critical Minerals Corp. has upgraded to the OTCQX Best Market from the OTCQB Venture Market, beginning trading under the symbol "PGEZF." This move enhances the company's visibility, liquidity, and accessibility to U.S. investors as it adva...
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
